Juniper Networks Disrupts Optical Market with Industry's

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
107
Juniper Networks Disrupts Optical Market with Industry's First Open, Disaggregated Optical Line System

SUNNYVALE, CA --(Marketwired - November 01, 2017) - Juniper Networks ( NYSE : JNPR ), an industry leader in automated, scalable and secure networks, today became the first networking vendor to announce it is disaggregating optical line system hardware from network control software, rolling out a new optical solution that brings unprecedented levels of flexibility, cost control and multi-layer visibility to packet-optical transport. Juniper's end-to-end metro packet transport portfolio gives service providers the necessary building blocks to deploy new services built on cloud, 5G, IoT, multi-gigabit broadband and other advanced technologies.

Closed, proprietary optical-transport networks that bind the transponder, optical line system and control software together significantly hinder service providers' ability to deploy an agile service delivery model. Juniper's new cloud-grade solution, including an open, programmable optical line system, as well as a microservices-based management and control platform, allows operators to deploy any transponder solution to keep costs down, optimize the photonic layer control plane, and maintain unmatched service continuity.

Aligning with Juniper's Cloud-Grade Networking initiative announced in June, the company's Programmable Photonic Layer open line system features the new TCX1000 Series Programmable ROADM . Combining open, standards-based application programming interfaces (APIs), the new proNX Optical Director management and control platform makes it easier for customers to deploy coherent DWDM transponders -- whether from Juniper, a service provider or third parties. Taking this platform-first approach, Juniper customers can rest assured they are operating a future-proof system, free from vendor lock-in.

News highlights:

  • Juniper Programmable Photonic Layer featuring the new TCX1000 Series Programmable ROADM: Part of a complete open line system solution, the TCX1000 Programmable ROADM, enabled by Lumentum, is a colorless, directionless, flex-grid ready programmable ROADM that allows operators to seamlessly upgrade to emerging high-capacity bit rates -- 100G, 200G, 400G and beyond -- without having to upgrade line system hardware. Operators can now confidently disaggregate the line system hardware from the transponder layer and from the photonic layer control plane to better optimize the network for use cases such as data center interconnect.
  • proNX Optical Director microservices-based optical network management and control software platform: Building on the strengths of proNX Service Manager's automated service activation and network management capabilities, proNX Optical Director uses a microservices-based architecture to enable operators to scale more effectively and simply integrate customer and third-party applications in an agile operational environment. Additionally, proNX Optical Director uses a standards-based YANG API to integrate seamlessly with Juniper Networks® NorthStar Controller, providing full network visibility and coordination from Layer 0 to Layer 3.

Supporting Quotes

"The continuously evolving dynamics presented by the cloud requires that all elements of the network be agile, open and easily disaggregated -- and Juniper is ensuring that the optical layer follows suit. Closed systems that prevent true agility abound, but Juniper understands the importance of disaggregation and we're excited to give customers the power to move faster within the cloud era with a true turnkey solution for end-to-end packet optical network operation."

– Donyel Jones-Williams, Director of Service Provider Portfolio Marketing, Juniper Networks

"Network operators require flexible, disaggregated optical line solutions supporting best-of-breed coherent modules. With the Programmable Photonic Layer and proNX Optical Director, Juniper becomes the first vendor to offer centralized, disaggregated open optical line system control software from the network hardware. Today's announcement shows Juniper is helping customers accelerate migration towards open, programmable packet-optical transport networks."

– Don Frey, principal analyst, Ovum

Additional Resources:

About Juniper Networks

Juniper Networks challenges the status quo with products, solutions and services that transform the economics of networking. Our team co-innovates with customers and partners to deliver automated, scalable and secure networks with agility, performance and value. Additional information can be found at Juniper Networks ( www.juniper.net ) or connect with Juniper on Twitter and Facebook .

Juniper Networks, the Juniper Networks logo, Juniper and Junos are registered trademarks of Juniper Networks, Inc. and/or its affiliates in the United States and other countries. Other names may be trademarks of their respective owners.

Forward-Looking Statements This press release contains forward-looking statements that involve a number of assumptions, uncertainties and risks including, among other things, statements concerning Juniper Networks' prospects, future products, product availability and performance, cost savings, achievement of operational efficiencies and other benefits to customers, and functionality with third party products. Actual results or events could differ materially from those anticipated in those forward-looking statements as a result of certain factors, including delays in scheduled product availability, incompatibility of technologies, the company's failure to accurately predict emerging technological trends, and other factors listed in Juniper Networks' most recent report on Form 10-K and Form 10-Q filed with the Securities and Exchange Commission. All statements made in this press release are made only as of the date of this press release. Juniper Networks undertakes no obligation to update the information in this press release in the event facts or circumstances subsequently change after the date of this press release. Any future product, feature, enhancement or related specification that may be referenced in this press release are for information purposes only, are subject to change at any time without notice and are not commitments to deliver any future product, feature, enhancement or related specification. The information contained in this press release is intended to outline Juniper Networks' general product direction and should not be relied on in making a purchasing decision.

Media Relations: Elliott Burr Juniper Networks (408) 936-7823 eburr@juniper.net

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stavian Group Eyes AI-Driven Southeast Asia Growth

Updated Category News Views 35

AI and Infrastructure: A New Chapter for Southeast Asia What does Southeast Asia's future look like with AI steering the ship? Well, there's a fresh breeze of change blowing, and right at the heart of it stands Stavian Group. At the recently held inaugural Fortune SEA500 Summit in Ho Chi Minh City, this conglomerate threw its hat into the ring, painting a vision of growth...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 51

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 119

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 291

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 595

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 321

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 337

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 0

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 273

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading

Top 5 Most Recently Viewed Articles

Market Reactions: Middle East Tensions and the Vance-Walz Debate

Updated Category News Views 71

Market Reactions to Middle East Tensions US stock futures are experiencing a downward trend as investors react to the escalating violence in the Middle East. With Iran claiming to have ceased its air bombardments on Israel, uncertainty still looms, as Israeli officials pledge a counterattack. This ongoing conflict has already impacted Wall Street, where equity values...

Continue Reading
Class Action Alert for Visa Inc. Shareholders Facing Losses

Updated Category News Views 91

Class Action Notification for Visa Inc. Shareholders The Gross Law Firm is reaching out to shareholders of Visa Inc. (NYSE: V) regarding an important class action that may affect them. If you purchased shares during a specific class period and have suffered losses, your participation could be significant in holding the company accountable. Understanding the Class Period...

Continue Reading
Coca-Cola's Earnings Report: Anticipated Insights and Analysis

Updated Category News Views 205

Coca-Cola's Earnings Report Overview The Coca-Cola Company (NYSE: KO) is on the cusp of unveiling its second-quarter financial results. Investors, analysts, and fans alike are closely watching what insights the beverage giant will provide during this crucial report. With notable figures in the U.S. market keeping an eye on Coca-Cola, the anticipation is palpable. Earnings...

Continue Reading
Maggiano's Unveils Gourmet Italian-American Classics Menu

Updated Category News Views 410

Introduction of Italian-American Classics at Maggiano's Maggiano's Little Italy is embracing the culinary heritage of Italian-American cuisine by introducing a new menu that reflects a dedication to high-quality ingredients and gourmet recipes. Under the expert guidance of award-winning Chef Anthony Amoroso, the restaurant's latest offerings promise to impress food...

Continue Reading
Recognizing Excellence: Pierce & O'Neill Founders Honored

Updated Category News Views 362

Pierce & O’Neill Founders Honored Among Top Attorneys Pierce & O’Neill, LLP, a renowned litigation boutique, is celebrating its founders, Jesse Pierce and Jack O’Neill, for their remarkable achievements in the legal field. Recently recognized in Lawdragon’s prestigious list of the 500 Leading Lawyers in America for 2025, this accolade showcases their exceptional...

Continue Reading